Invention Application
![PYRAZOLO[3,4-B]PYRIDINES AND IMIDAZO[1,5-B]PYRIDAZINES AS PDE1 INHIBITORS](/docs/US/2019-11-21/US20190352302A1/abs.jpg.600x600.jpg)
- Patent Title: PYRAZOLO[3,4-B]PYRIDINES AND IMIDAZO[1,5-B]PYRIDAZINES AS PDE1 INHIBITORS
-
Application No.: US16424585Application Date: 2019-05-29
-
Publication No.: US20190352302A1Publication Date: 2019-11-21
- Inventor: Jan Kehler , Lars Kyhn Rasmussen , Morten Langgård , Mikkel Jessing , Paulo Jorge Vieira Vital , Karsten Juhl , Mauro Marigo
- Applicant: H. Lundbeck A/S
- Priority: DKPA201600784 20161222; DKPA201700404 20170706
- Main IPC: A61K31/502
- IPC: A61K31/502 ; C07D471/04 ; C07D519/00 ; C07D487/04 ; A61P25/28 ; A61P25/00 ; A61P25/18 ; A61P25/16
![PYRAZOLO[3,4-B]PYRIDINES AND IMIDAZO[1,5-B]PYRIDAZINES AS PDE1 INHIBITORS](/abs-image/US/2019/11/21/US20190352302A1/abs.jpg.150x150.jpg)
Abstract:
The present invention provides compounds of formula (I) that are PDE1 enzyme inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.
Public/Granted literature
- US10689379B2 Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors Public/Granted day:2020-06-23
Information query
IPC分类:
